Phase 2b Study of the Clinical Efficacy and Safety of Collagenase Clostridium Histolyticum in Patients With Peyronie Disease
The Journal of Urology, 05/10/2012
Gelbard M et al. – Collagenase clostridium histolyticum treatment was well tolerated. The authors noted significant improvement in penile curvature and patient reported outcome symptom bother scores, suggesting that this may be a safe, nonsurgical alternative for Peyronie disease.
